Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. / Karttunen, Eemil; Hervonen, Petteri; Hosseini Aliabad, Abolfazl; Oldenburg, Jan; Pappot, Helle; Sairanen, Jukka; Støvring, Henrik; Vásquez, Juan Luis; Bergman, Suzanne; Magnussen, Gry; Norremark, Pernille; Thoresen, Steinar; Ullén, Anders.

I: Scandinavian Journal of Urology, Bind 57, Nr. 1-6, 2023, s. 15-21.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Karttunen, E, Hervonen, P, Hosseini Aliabad, A, Oldenburg, J, Pappot, H, Sairanen, J, Støvring, H, Vásquez, JL, Bergman, S, Magnussen, G, Norremark, P, Thoresen, S & Ullén, A 2023, 'Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019', Scandinavian Journal of Urology, bind 57, nr. 1-6, s. 15-21. https://doi.org/10.1080/21681805.2022.2138965

APA

Karttunen, E., Hervonen, P., Hosseini Aliabad, A., Oldenburg, J., Pappot, H., Sairanen, J., Støvring, H., Vásquez, J. L., Bergman, S., Magnussen, G., Norremark, P., Thoresen, S., & Ullén, A. (2023). Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. Scandinavian Journal of Urology, 57(1-6), 15-21. https://doi.org/10.1080/21681805.2022.2138965

Vancouver

Karttunen E, Hervonen P, Hosseini Aliabad A, Oldenburg J, Pappot H, Sairanen J o.a. Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. Scandinavian Journal of Urology. 2023;57(1-6):15-21. https://doi.org/10.1080/21681805.2022.2138965

Author

Karttunen, Eemil ; Hervonen, Petteri ; Hosseini Aliabad, Abolfazl ; Oldenburg, Jan ; Pappot, Helle ; Sairanen, Jukka ; Støvring, Henrik ; Vásquez, Juan Luis ; Bergman, Suzanne ; Magnussen, Gry ; Norremark, Pernille ; Thoresen, Steinar ; Ullén, Anders. / Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. I: Scandinavian Journal of Urology. 2023 ; Bind 57, Nr. 1-6. s. 15-21.

Bibtex

@article{ec1d46df61294b4294dd702953db565b,
title = "Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019",
abstract = "Purpose: To understand the potential impact of new treatment options for urinary tract cancer, recent population trends in incidence, mortality and survival should be elucidated. This study estimated changes in the incidence, mortality and relative survival of urinary tract cancer in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) between 1990 and 2019. Methods: Annual counts of incident cases and deaths due to urinary tract cancer (International Classification of Diseases, Tenth Revision, Clinical Modification codes C65–C68, D09.0–D09.1, D30.1–D30.9 and D41.1–D41.9) in Nordic countries were retrieved in 5-year age categories by sex during the study period. Country-specific time trends (annual rate ratios [RRs]) were estimated using Poisson regression, and RRs were compared between sexes. Results: The incidence rate of bladder and upper urothelial tract cancer was >3-times lower in women than men in all countries across all age groups (incidence RR for women to men ranging from 0.219 [95% CI = 0.213–0.224] in Finland to 0.291 [95% CI = 0.286–0.296] in Denmark). Incidence rates were lowest in Finland and highest in Norway and Denmark. Age-adjusted mortality decreased in Finland, Denmark and Norway and in Swedish men, with the greatest decrease seen in Danish men (annual RR = 0.976; 95% CI = 0.975–0.978). In all countries and age groups, women had a lower relative survival rate than men. Conclusion: Between 1990 and 2019, the incidence of urinary tract cancer was stable in the Nordic countries, while mortality rates declined and relative survival increased. This could be due to earlier diagnosis and better treatment.",
keywords = "Bladder cancer, epidemiology, NORDCAN, Nordic countries, urinary tract cancer, urology",
author = "Eemil Karttunen and Petteri Hervonen and {Hosseini Aliabad}, Abolfazl and Jan Oldenburg and Helle Pappot and Jukka Sairanen and Henrik St{\o}vring and V{\'a}squez, {Juan Luis} and Suzanne Bergman and Gry Magnussen and Pernille Norremark and Steinar Thoresen and Anders Ull{\'e}n",
note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",
year = "2023",
doi = "10.1080/21681805.2022.2138965",
language = "English",
volume = "57",
pages = "15--21",
journal = "Scandinavian Journal of Urology",
issn = "2168-1805",
publisher = "Taylor & Francis",
number = "1-6",

}

RIS

TY - JOUR

T1 - Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019

AU - Karttunen, Eemil

AU - Hervonen, Petteri

AU - Hosseini Aliabad, Abolfazl

AU - Oldenburg, Jan

AU - Pappot, Helle

AU - Sairanen, Jukka

AU - Støvring, Henrik

AU - Vásquez, Juan Luis

AU - Bergman, Suzanne

AU - Magnussen, Gry

AU - Norremark, Pernille

AU - Thoresen, Steinar

AU - Ullén, Anders

N1 - Publisher Copyright: © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

PY - 2023

Y1 - 2023

N2 - Purpose: To understand the potential impact of new treatment options for urinary tract cancer, recent population trends in incidence, mortality and survival should be elucidated. This study estimated changes in the incidence, mortality and relative survival of urinary tract cancer in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) between 1990 and 2019. Methods: Annual counts of incident cases and deaths due to urinary tract cancer (International Classification of Diseases, Tenth Revision, Clinical Modification codes C65–C68, D09.0–D09.1, D30.1–D30.9 and D41.1–D41.9) in Nordic countries were retrieved in 5-year age categories by sex during the study period. Country-specific time trends (annual rate ratios [RRs]) were estimated using Poisson regression, and RRs were compared between sexes. Results: The incidence rate of bladder and upper urothelial tract cancer was >3-times lower in women than men in all countries across all age groups (incidence RR for women to men ranging from 0.219 [95% CI = 0.213–0.224] in Finland to 0.291 [95% CI = 0.286–0.296] in Denmark). Incidence rates were lowest in Finland and highest in Norway and Denmark. Age-adjusted mortality decreased in Finland, Denmark and Norway and in Swedish men, with the greatest decrease seen in Danish men (annual RR = 0.976; 95% CI = 0.975–0.978). In all countries and age groups, women had a lower relative survival rate than men. Conclusion: Between 1990 and 2019, the incidence of urinary tract cancer was stable in the Nordic countries, while mortality rates declined and relative survival increased. This could be due to earlier diagnosis and better treatment.

AB - Purpose: To understand the potential impact of new treatment options for urinary tract cancer, recent population trends in incidence, mortality and survival should be elucidated. This study estimated changes in the incidence, mortality and relative survival of urinary tract cancer in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) between 1990 and 2019. Methods: Annual counts of incident cases and deaths due to urinary tract cancer (International Classification of Diseases, Tenth Revision, Clinical Modification codes C65–C68, D09.0–D09.1, D30.1–D30.9 and D41.1–D41.9) in Nordic countries were retrieved in 5-year age categories by sex during the study period. Country-specific time trends (annual rate ratios [RRs]) were estimated using Poisson regression, and RRs were compared between sexes. Results: The incidence rate of bladder and upper urothelial tract cancer was >3-times lower in women than men in all countries across all age groups (incidence RR for women to men ranging from 0.219 [95% CI = 0.213–0.224] in Finland to 0.291 [95% CI = 0.286–0.296] in Denmark). Incidence rates were lowest in Finland and highest in Norway and Denmark. Age-adjusted mortality decreased in Finland, Denmark and Norway and in Swedish men, with the greatest decrease seen in Danish men (annual RR = 0.976; 95% CI = 0.975–0.978). In all countries and age groups, women had a lower relative survival rate than men. Conclusion: Between 1990 and 2019, the incidence of urinary tract cancer was stable in the Nordic countries, while mortality rates declined and relative survival increased. This could be due to earlier diagnosis and better treatment.

KW - Bladder cancer

KW - epidemiology

KW - NORDCAN

KW - Nordic countries

KW - urinary tract cancer

KW - urology

U2 - 10.1080/21681805.2022.2138965

DO - 10.1080/21681805.2022.2138965

M3 - Journal article

C2 - 36416403

AN - SCOPUS:85142600942

VL - 57

SP - 15

EP - 21

JO - Scandinavian Journal of Urology

JF - Scandinavian Journal of Urology

SN - 2168-1805

IS - 1-6

ER -

ID: 335024406